BioNeutra Global Financials
| BGACF Stock | USD 0.01 0.00 0.00% |
BioNeutra |
Understanding current and past BioNeutra Global Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of BioNeutra Global's financial statements are interrelated, with each one affecting the others. For example, an increase in BioNeutra Global's assets may result in an increase in income on the income statement.
BioNeutra Global Stock Summary
BioNeutra Global competes with GNS. BioNeutra Global Corporation, together with its subsidiaries, engages in the research and development, production, and commercialization of food ingredients for nutraceutical, functional, and mainstream foods, and beverages with a focus on oligosaccharides. The company provides VitaFiber through Amazon.com and Shopify.com, as well as other direct-to-consumer retail channels. Bioneutra Global is traded on OTC Exchange in the United States.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 9608 - 25 |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Benchmark | Dow Jones Industrial |
| Website | www.bioneutra.ca |
| Phone | 780 466 1481 |
| Currency | USD - US Dollar |
BioNeutra Global Key Financial Ratios
There are many critical financial ratios that BioNeutra Global's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that BioNeutra Global reports annually and quarterly.| Return On Equity | -2.55 | |||
| Return On Asset | -0.0573 | |||
| Beta | 0.74 |
BioNeutra Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining BioNeutra Global's current stock value. Our valuation model uses many indicators to compare BioNeutra Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across BioNeutra Global competition to find correlations between indicators driving BioNeutra Global's intrinsic value. More Info.BioNeutra Global is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the BioNeutra Global's earnings, one of the primary drivers of an investment's value.BioNeutra Global Systematic Risk
BioNeutra Global's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. BioNeutra Global volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on BioNeutra Global correlated with the market. If Beta is less than 0 BioNeutra Global generally moves in the opposite direction as compared to the market. If BioNeutra Global Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one BioNeutra Global is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of BioNeutra Global is generally in the same direction as the market. If Beta > 1 BioNeutra Global moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for BioNeutra Pink Sheet analysis
When running BioNeutra Global's price analysis, check to measure BioNeutra Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNeutra Global is operating at the current time. Most of BioNeutra Global's value examination focuses on studying past and present price action to predict the probability of BioNeutra Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNeutra Global's price. Additionally, you may evaluate how the addition of BioNeutra Global to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |